RenovoRx, Inc.
RNXT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001574094
No open-market purchases or sales by RenovoRx, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $9.00M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding RenovoRx, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 9 | 12 | +3 |
| Shares | 104.4K | 164.8K | +60.4K (+57.8%) |
| Value | $506.0K | $482.0K | −$24.0K (−4.7%) |
New holders (8)
Institutions that held RenovoRx, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cohen Lawrence B | 54,121 | $159.0K | 0.09% |
| Stifel Financial Corp | 29,143 | $85.0K | 0.00% |
| Susquehanna International Group, LLP | 18,582 | $54.0K | 0.00% |
| Colony Group LLC | 15,508 | $45.0K | 0.00% |
| Bank of America Corp | 14,802 | $44.0K | 0.00% |
| Vanguard Group Inc | 10,815 | $32.0K | 0.00% |
| Morgan Stanley | 3,852 | $11.0K | 0.00% |
| BlackRock Inc. | 429 | $1.00K | 0.00% |
Sold out (5)
Institutions that held RenovoRx, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Board of Trustees of The Leland Stanford Junior University | 60,863 | $295.0K |
| Virtu Financial LLC | 13,208 | $64.0K |
| Verition Fund Management LLC | 10,283 | $50.0K |
| UBS Group AG | 4,512 | $22.0K |
| Carmichael Hill & Associates, Inc. | 200 | $1.00K |